• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

花生过敏的现行和未来治疗方法。

Current and Future Treatment of Peanut Allergy.

机构信息

Emory University School of Medicine, Atlanta, Ga.

Sagamihara National Hospital, Sagamihara, Japan.

出版信息

J Allergy Clin Immunol Pract. 2019 Feb;7(2):357-365. doi: 10.1016/j.jaip.2018.11.049.

DOI:10.1016/j.jaip.2018.11.049
PMID:30717866
Abstract

Based on productive translational research programs conducted over the last 20 years, the clinical landscape of peanut allergy is now rapidly changing. In this review, we review data from recent trials of investigational peanut oral and epicutaneous immunotherapies, explore the pipeline of novel therapies in early development, and identify future research needs and priorities.

摘要

基于过去 20 年开展的富有成效的转化研究计划，花生过敏的临床格局正在迅速改变。在这篇综述中，我们回顾了最近关于研究性花生口服和皮内免疫疗法的试验数据，探讨了早期开发的新型疗法的研发管道，并确定了未来的研究需求和重点。

相似文献

1
Current and Future Treatment of Peanut Allergy.花生过敏的现行和未来治疗方法。
J Allergy Clin Immunol Pract. 2019 Feb;7(2):357-365. doi: 10.1016/j.jaip.2018.11.049.
2
Oral Immunotherapy for Peanut Allergy.口服免疫疗法治疗花生过敏
Annu Rev Med. 2016;67:375-85. doi: 10.1146/annurev-med-061014-094943. Epub 2015 Aug 26.
3
Peanut Oral Immunotherapy: State of the Art.花生口服免疫治疗：最新进展。
Immunol Allergy Clin North Am. 2020 Feb;40(1):97-110. doi: 10.1016/j.iac.2019.09.005. Epub 2019 Nov 6.
4
Epicutaneous peanut patch device for the treatment of peanut allergy.经皮花生贴片装置治疗花生过敏。
Expert Rev Clin Immunol. 2019 May;15(5):449-460. doi: 10.1080/1744666X.2019.1593138. Epub 2019 Mar 27.
5
Administration of a probiotic with peanut oral immunotherapy: A randomized trial.口服花生免疫治疗联合益生菌治疗：一项随机试验。
J Allergy Clin Immunol. 2015 Mar;135(3):737-44.e8. doi: 10.1016/j.jaci.2014.11.034. Epub 2015 Jan 13.
6
Low dose immunotherapy in very young children to treat peanut allergy.低剂量免疫疗法用于幼儿治疗花生过敏。
Expert Rev Clin Immunol. 2016 Dec;12(12):1251-1253. doi: 10.1080/1744666X.2016.1226131. Epub 2016 Sep 12.
7
Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.日本儿童过敏性花生过敏的低剂量口服免疫治疗。
Pediatr Allergy Immunol. 2018 Aug;29(5):512-518. doi: 10.1111/pai.12898. Epub 2018 May 10.
8
Current opinion and review on peanut oral immunotherapy.关于花生口服免疫疗法的当前观点与综述
Hum Vaccin Immunother. 2014;10(10):3017-21. doi: 10.4161/hv.32190.
9
Current perspectives on peanut allergy.花生过敏的最新观点。
Intern Med J. 2019 Dec;49(12):1480-1487. doi: 10.1111/imj.14658.
10
Current Trend in Immunotherapy for Peanut Allergy.花生过敏的免疫治疗新趋势
Int Rev Immunol. 2018;37(6):279-290. doi: 10.1080/08830185.2018.1509967. Epub 2019 Jan 13.

引用本文的文献

1
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding.Ara h 2 N 端 IgE 结合表位的精细解析：发现具有增强 IgE 结合能力的变体
J Allergy Clin Immunol. 2025 Apr 29. doi: 10.1016/j.jaci.2025.03.032.
2
Re-evaluating treatment success in trials of peanut oral-immunotherapy: impact of different definitions on efficacy outcomes.重新评估花生口服免疫疗法试验中的治疗成功率：不同定义对疗效结果的影响。
Curr Opin Allergy Clin Immunol. 2025 Jun 1;25(3):185-193. doi: 10.1097/ACI.0000000000001077. Epub 2025 Apr 10.
3
Probiotics and other adjuvants in allergen-specific immunotherapy for food allergy: a comprehensive review.
用于食物过敏的变应原特异性免疫疗法中的益生菌及其他佐剂：一项全面综述
Front Allergy. 2024 Oct 10;5:1473352. doi: 10.3389/falgy.2024.1473352. eCollection 2024.
4
Design of an Ara h 2 hypoallergen from conformational epitopes.设计一种 Ara h 2 变应原，基于构象表位。
Clin Exp Allergy. 2024 Jan;54(1):46-55. doi: 10.1111/cea.14433. Epub 2024 Jan 2.
5
Pathophysiological, Cellular, and Molecular Events of the Vascular System in Anaphylaxis.过敏反应中血管系统的病理生理学、细胞和分子事件。
Front Immunol. 2022 Mar 8;13:836222. doi: 10.3389/fimmu.2022.836222. eCollection 2022.
6
Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses.口服脱敏疗法治疗花生过敏可诱导花生特异性免疫应答的动态变化。
Allergy. 2022 Aug;77(8):2534-2548. doi: 10.1111/all.15276. Epub 2022 Mar 14.
7
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.口服免疫治疗在 1-3 岁花生过敏儿童中的疗效和安全性（免疫耐受网络 IMPACT 试验）：一项随机安慰剂对照研究。
Lancet. 2022 Jan 22;399(10322):359-371. doi: 10.1016/S0140-6736(21)02390-4.
8
Incidence of anaphylaxis and accidental peanut exposure: A systematic review.过敏反应和意外花生暴露的发生率：一项系统综述。
Clin Transl Allergy. 2021 Oct;11(8):e12064. doi: 10.1002/clt2.12064.
9
Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate.食物过敏儿童的口服免疫治疗：赞成与反对观点辩论。
Front Immunol. 2021 Sep 28;12:636612. doi: 10.3389/fimmu.2021.636612. eCollection 2021.
10
Mechanisms of oral immunotherapy.口服免疫疗法的机制。
Clin Exp Allergy. 2021 Apr;51(4):527-535. doi: 10.1111/cea.13824. Epub 2021 Jan 20.